PHGE (STOCKS)
BiomX Inc.
$2.150300
-0.479700 (-18.24%)
Prev close: $2.630000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Michael Oster
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $14.07M
- Employees
- 57
- P/E (TTM)
- -0.11
- P/B (TTM)
- -0.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-8.17 | $-4.70 | -3.4678 | -73.75% |
|
Sep 2025 (Q3)
|
$-5.51 | $-6.20 | +0.6916 | +11.15% |
|
Jun 2025 (Q2)
|
$-3.61 | $-6.30 | +2.6885 | +42.68% |
|
Mar 2025 (Q1)
|
$-6.27 | $-6.98 | +0.7068 | +10.13% |
Financial Statements
| Nonoperating Income/Loss | -$724.00K |
| Research and Development | $21.29M |
| Operating Income/Loss | -$41.47M |
| Income/Loss From Continuing Operations After Tax | -$36.20M |
| Income/Loss From Continuing Operations Before Tax | -$36.19M |
| Income Tax Expense/Benefit | $7.00K |
| Net Income/Loss | -$36.20M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$36.20M |
| Net Income/Loss Available To Common Stockholders, Basic | -$36.20M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $22.19 |
| Diluted Earnings Per Share | $22.19 |
| Basic Average Shares | 1,631,037 |
| Diluted Average Shares | 1,631,037 |
| Assets | $5.78M |
| Current Assets | $5.58M |
| Noncurrent Assets | $208.00K |
| Liabilities | $7.09M |
| Current Liabilities | $6.38M |
| Noncurrent Liabilities | $706.00K |
| Equity | -$1.30M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$1.30M |
| Liabilities And Equity | $5.78M |
| Net Cash Flow From Operating Activities | -$26.39M |
| Net Cash Flow From Operating Activities, Continuing | -$26.39M |
| Net Cash Flow From Investing Activities | $108.00K |
| Net Cash Flow From Investing Activities, Continuing | $108.00K |
| Net Cash Flow From Financing Activities | $13.19M |
| Net Cash Flow From Financing Activities, Continuing | $13.19M |
| Exchange Gains/Losses | $73.00K |
| Net Cash Flow | -$13.02M |
| Net Cash Flow, Continuing | -$13.09M |
| Comprehensive Income/Loss | -$36.20M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$36.20M |
| Other Comprehensive Income/Loss | $0.00 |